Khiron begins dispensation of insurance-covered prescriptions in Colombia

TORONTO –

Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), announces that it has begun dispensing medical cannabis to patients in its wholly owned ZereniaTM clinic, under the insurance coverage system approved by the Government of Colombia on January 1st, 2023.

ZereniaTM is a healthcare network of specialized clinics focused on treating chronic pain, neurological conditions, mental health, and sleep disorders. It is the leading medical cannabis clinic network in Colombia, as evidenced by its recent contract with Colombia´s largest public insurance company. In 2022, in Colombia alone, the clinic network had more than 130,000 individual consultations, up 20% from 2021, and it has a physical capacity of up to 300,000 consultations per year. In the first half of 2022, more than 40% of all consults resulted in a medical cannabis prescription. ZereniaTM has locations in Colombia, UK, Brazil, and Peru.

Alvaro Torres, CEO of Khiron, comments: “Thanks to the wise decision from the Government of Colombia to cover medical cannabis prescriptions, more and more of our patients are leaving our clinics with funded life-changing medication. It´s great to see that medical cannabis is now an integral part of the patient journey towards improving their quality of life. Our Zerenia clinics are recognized nationwide by patients, doctors, insurance companies, and the Government, for our unique healthcare model and we will continue to lead the disruption of medical cannabis in Colombia and abroad.”

About Khiron Life Sciences Corp.

Khiron is a leading global medical cannabis company with core operations in Latin America and Europe. Leveraging wholly owned medical health clinics and proprietary telemedicine platforms, Khiron combines a patient-oriented approach, physician education programs, scientific expertise, product innovation, and focus on creating access to drive prescriptions and brand loyalty with patients worldwide. The Company has a sales presence in Colombia, Germany, the United Kingdom, Switzerland, Peru, and Brazil. The Company is led by its co-founder and Chief Executive Officer, Alvaro Torres, together with an experienced and diverse executive team and board of directors.

Visit Khiron online at https://investors.khiron.ca.

Linkedin https://www.linkedin.com/company/khiron-life-sciences-corp/